About Cephalon
Cephalon is a company based in Frazer (United States) founded in 1987 was acquired by Teva Pharmaceuticals in October 2011. Cephalon has completed 6 acquisitions, including Arana, Ception Therapeutics and ChemGenex Pharmaceuticals.
- Headquarter Frazer, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Arana
& 5 more
-
Acquired by
Teva Pharmaceuticals
(Oct 14, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cephalon
Detailed funding history for Cephalon
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cephalon
Cephalon has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Teva Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals.
|
Locked | Locked | Locked |
Investor details for Cephalon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cephalon
Cephalon has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Arana, Ception Therapeutics and ChemGenex Pharmaceuticals.
Investment portfolio details for Cephalon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drugs for inflammatory conditions are discovered, developed, and commercialized.
|
Locked | Locked | 2004 | Locked | |
|
Drugs for hematologic cancers are developed using prior clinical data.
|
Locked | Locked | 2000 | Locked | |
|
Specialty company developing oncology drugs
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Cephalon
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Cephalon
Detailed financials for Cephalon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cephalon Comparisons
Peer comparison for Cephalon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cephalon
Detailed competitors of Cephalon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cephalon
Complete news archive for Cephalon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cephalon
Cephalon was founded in 1987.
Cephalon is headquartered in Frazer, United States. It is registered at Frazer, Pennsylvania, United States.
Founded in 1987 and headquartered in Frazer, United States, Cephalon is involved in the pharmaceutical sector, where therapeutics for central nervous system disorders, pain management, and oncology are developed, manufactured, and marketed. Products such as Nuvigil for narcolepsy, Treanda for non-Hodgkins lymphoma and chronic lymphocytic leukemia, and Amrix as a muscle relaxant are offered. Operations as a subsidiary of Teva Pharmaceuticals have been maintained since October 2011.
Cephalon has made 6 acquisitions, including Arana, Ception Therapeutics, and ChemGenex Pharmaceuticals.
Cephalon has 1 investor. Key investors include Teva Pharmaceuticals.